AVLN

AVLN is in a clear downtrend with EMAs declining and no structural bullish patterns. Recent rallies into the 9/20 EMA have been rejected, signaling renewed distribution. With RSI in extreme oversold territory but sell-side momentum still intact, the optimal engagement is to sell now on resistance. Caution is warranted for potential sharp bounces, but overall bearish posture remains dominant across horizons.

• ↑AP01 inhaled Pirfenidone Phase 2b enrollment complete; topline data due late 2027
• ↑$14.99M insider purchases in past 3 months underscore management conviction
• ↓Earnings yield negative and profitability metrics signal poor financial health